Voluntary announcement first patient enrolled in phase iii clinical trial of anaprazole sodium for helicobacter pylori eradication
· Issued by Xuanzhu Biopharmaceutical Co., Ltd. Class H via HKEXnews
Xuanzhu Biopharmaceutical Co., Ltd. Class H (2575) Press Release
View Attachment
